09:55 AM EST - Avant Technologies Inc : Announced its participation in the 15th European Pancreas and Islet Transplantation Association (EPITA) Symposium, held January 25-27, 2026, in Igls, Austria. As a leader in immunosuppression-free cell therapy solutions, Avant is actively evaluating advanced cells for potential application in a diabetes therapy at this premier European event. Avant Technologies Inc
shares O.AVAI are trading unchanged at $0.71.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=AVAI&qmodStoryID=5611686510940997
